Renal Cell Carcinoma Metastatic
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma Metastatic.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: High Dose IL-2 in Combination With Anti-PD-1 [Phase 2]
Phase 2 trial evaluating high-dose interleukin-2 in combination with anti-PD-1 in melanoma and renal cell carcinoma (metastatic); study term…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
This clinical trial investigates cabozantinib as monotherapy or in combination with nivolumab for first-line treatment of advanced or metast…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 [Phase 1, Phase 2]
A Phase 1b/2 clinical trial evaluating the monoclonal antibody OM-RCA-01 in metastatic tumors expressing FGFR1 is currently recruiting acros…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma [Phase 4]
A Phase 4 clinical trial evaluating digital monitoring of self-reported symptoms in patients with advanced renal cell carcinoma treated with…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Role of PRoactivE Coaching on PAtient REported Outcome in Advanced or Metastatic RCC Treated With Sunitinib or a Combination of Pembrolizumab + Axitinib or Avelumab + Axitinib in First Line Therapy [Phase 3]
Phase 3 trial evaluating the impact of PRO coaching on patient-reported outcomes in frontline advanced or metastatic renal cell carcinoma, c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy [Phase 2]
Clinical trial update for the Phase 2 study CLARA investigating somatic and germline factors that influence renal cancer immunotherapy respo…
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC) [Phase 2]
Phase 2 trial comparing intratumoral vaccination with Intuvax followed by sunitinib after nephrectomy versus sunitinib after nephrectomy in …
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Sorafenib in Elderly mRCC
Completed clinical trial update on sorafenib in elderly patients with metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung [Phase 2]
A Phase 2 trial evaluating sargramostim for metastatic renal cell carcinoma with lung metastases has been completed. The provided snippet do…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast [NA]
This completed study evaluated the intra-patient variability of quantitative ultrasound contrast–based tumor perfusion parameters. It includ…
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer
A terminated clinical trial evaluating serum CA9 as a biomarker of treatment response in metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) [Phase 2]
A Phase 2 study of M200 (volociximab) in metastatic renal cell carcinoma was terminated.
-
CLINICAL_TRIALS approval · 2012-03-09Clinical Trial Update: Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Pfizer's sunitinib (SU011248) has been approved for marketing for use in cytokine-refractory metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial evaluated the combination of capecitabine and GTI-2040 for renal cell carcinoma, including metastatic case…